Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Results 1 - 20 of 40 : 1 2 Next »

Recs

0
Member Avatar andrewtraylor (60.86) Submitted: 4/16/2015 5:06:12 PM : Outperform Start Price: $182.00 ALXN Score: -2.35

Good ROE, profit margins and growth

Recs

0
Member Avatar Juggernaut0609 (91.31) Submitted: 4/1/2015 11:44:17 AM : Outperform Start Price: $168.26 ALXN Score: +4.15

Huge growth, no debt, lots of cash.

Recs

0
Member Avatar Defshark82 (71.99) Submitted: 12/31/2014 11:44:44 AM : Outperform Start Price: $187.71 ALXN Score: -5.85

Tracking JPM top pick

Recs

1
Member Avatar Tophinater (40.81) Submitted: 10/24/2014 10:13:29 AM : Outperform Start Price: $187.36 ALXN Score: -12.30

Sure, why not?

Recs

0
Member Avatar pchop123 (80.45) Submitted: 7/13/2014 6:55:12 PM : Outperform Start Price: $164.32 ALXN Score: +2.49

upside in price very likely

Recs

1
Member Avatar BigFatBEAR (28.99) Submitted: 7/9/2014 4:22:34 PM : Outperform Start Price: $161.62 ALXN Score: +3.01

Too rich for my real cash at this level, but loved enough by informed folks, such as zzlangerhans, to make me a watcher. Low beta, which could be quite handy in a selloff, but I'm guessing this thing will kiss $100 someday in the next year or two, what with biotech being volatile and all.

Appears to be one of the best-of-breed in the sector, so if you're going to own individual stocks instead of IBB, might as well go this route.

Recs

0
Member Avatar poluh2k (44.42) Submitted: 6/9/2014 8:44:39 AM : Underperform Start Price: $170.02 ALXN Score: +2.43

p/e 103
p/s 12
p/fcf 89
not good for long and not bad for short

Recs

0
Member Avatar SnowBawl (< 20) Submitted: 5/5/2014 9:35:59 AM : Outperform Start Price: $155.11 ALXN Score: +2.80

13 classic growth stocks (Sterman).

Recs

0
Member Avatar TerryFool (82.44) Submitted: 3/7/2014 10:51:40 AM : Outperform Start Price: $164.85 ALXN Score: -3.24

BUY@ 165 1YR EPS 130% 2YR EPS 200% TP 188

Recs

0
Member Avatar Dudeone (93.20) Submitted: 2/12/2014 6:35:18 PM : Outperform Start Price: $174.23 ALXN Score: -13.68

Soliris continuing to grow and good products in pipeline e.g. asfotase

Recs

0
Member Avatar billyw10 (< 20) Submitted: 1/3/2014 6:26:30 PM : Outperform Start Price: $131.66 ALXN Score: +21.42

orphan drug alxn

Recs

0
Member Avatar CarlosDK (< 20) Submitted: 1/10/2013 8:12:04 AM : Underperform Start Price: $100.68 ALXN Score: -34.62

expensive on all valuations

Recs

0
Member Avatar ayuddha (39.05) Submitted: 7/15/2012 5:18:50 PM : Outperform Start Price: $96.87 ALXN Score: +29.63

It was picked by www.hechtsoft.de Trade Alerts.

Recs

1
Member Avatar danrifenburgh (< 20) Submitted: 12/19/2011 1:25:55 PM : Outperform Start Price: $67.44 ALXN Score: +92.16

After a 60% run-up, this volatile stock seems due for a fall. TM P/E of 82.96 with expected earnings growth of 31.54% taking it to a forward P/E of 38.81 next year. ALXN also trades at a premium to S&P500 TTM P/E. The PEG stands at 2.24, this could suggest some overvaluation. The Price/Book is 11.62.

Recs

1
Member Avatar rannici (< 20) Submitted: 10/27/2011 9:24:45 AM : Outperform Start Price: $67.84 ALXN Score: +99.62

just following the trend...

Recs

1
Member Avatar tradingblues1 (72.59) Submitted: 10/13/2011 7:05:08 PM : Outperform Start Price: $68.08 ALXN Score: +90.90

soaring to the moon!!

Recs

0
Member Avatar SIDRWC (69.41) Submitted: 9/28/2011 2:50:23 AM : Outperform Start Price: $67.62 ALXN Score: +86.61

The long-term potential growth for this company is astronomical... They seem to have incredible moment at this point, and is closely linked to stock-market turbulence. Very excited for this companies potential, and am buying in for the long hall.

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 7/25/2011 11:36:06 AM : Outperform Start Price: $58.67 ALXN Score: +149.04

ibd

Recs

0
Member Avatar mrindependent (61.80) Submitted: 11/24/2010 1:30:43 PM : Underperform Start Price: $38.21 ALXN Score: -295.21

Found this stock with a screen that looks for stocks that are stratospherically valued based on high expectations. CAPS score of 2 is higher than expected, which indicates that somebody likes this stock at this price. The deciding factor for me was the negative commentary from ZZLangerhans.

Recs

0
Member Avatar CramersSkeeDaddy (97.65) Submitted: 10/13/2010 12:01:39 PM : Outperform Start Price: $34.08 ALXN Score: +349.31

biotech spec 3

Results 1 - 20 of 40 : 1 2 Next »

Featured Broker Partners


Advertisement